Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
Clinical trial NCT01722045 · COMPLETED
Trial details
- NCT number
- NCT01722045
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-09-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.